List view / Grid view

Roman Thomas (DISCO Pharmaceuticals)

 

article

Could illuminating the surfaceome help find new targeted cancer therapies?

At the heart of precision oncology is the need to…

11 July 2024 | By

At the heart of precision oncology is the need to increase our understanding and knowledge of surface proteins found on tumour cells. Here Roman Thomas, CEO of DISCO Pharmaceuticals, explains how it is using cutting-edge technology to explore the surfaceome – a map of the proteins on the cell’s surface…